{"id":612886,"date":"2026-09-11T03:07:19","date_gmt":"2026-09-11T03:07:19","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/612886\/the-global-vascular-grafts-market-size-is-projected-to-grow-at-a-cagr-of-686-during-the-forecast-period-from-2025-to-2032-delveinsight.html"},"modified":"2026-09-11T03:07:19","modified_gmt":"2026-09-11T03:07:19","slug":"the-global-vascular-grafts-market-size-is-projected-to-grow-at-a-cagr-of-686-during-the-forecast-period-from-2025-to-2032-delveinsight","status":"publish","type":"post","link":"https:\/\/www.pennsylvania-magazine.com\/news\/story\/612886\/the-global-vascular-grafts-market-size-is-projected-to-grow-at-a-cagr-of-686-during-the-forecast-period-from-2025-to-2032-delveinsight.html","title":{"rendered":"The Global Vascular Grafts Market Size is projected to grow at a CAGR of 6.86% during the forecast period from 2025 to 2032 | DelveInsight"},"content":{"rendered":"<div style=\"font-style:italic;padding:8px 0px\">The Vascular Grafts market was valued at USD 1,863.09 million in 2024 and is projected to reach USD 3,153.39 million by 2032, growing at a CAGR of 6.86% during the forecast period from 2025 to 2032. Growth is anchored in the rising prevalence of cardiovascular diseases, increasing incidence of peripheral artery disease, and a growing volume of vascular and endovascular surgical procedures.<\/div>\n<p style=\"text-align: justify\">(Albany , US) , September 10 , 2026 &#8211; DelveInsight&#8217;s Vascular Grafts Market Insights Report 2032 provides the current and forecast market analysis, individual leading Vascular Grafts companies&#8217; market shares, challenges, Vascular Grafts Market Drivers, barriers, trends, and key market Vascular Grafts companies in the market.<\/p>\n<p style=\"text-align: justify\"><em><strong>To read more about the latest highlights related to the Vascular Grafts Market @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vascular-grafts-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\">Key Takeaways from the Vascular Grafts Market Report<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p class=\"caps\">In January 2026, Maastricht University Medical Center initiated the FLOW trial to evaluate follow-up strategies for vascular access in hemodialysis patients, assessing whether discontinuing active flow-volume surveillance is safe. Strategic significance: Could reshape clinical protocols for monitoring vascular access stenosis in dialysis patients.<\/p>\n<\/li>\n<li>\n<p>In August 2024, Terumo India launched the TREO&reg; Stent-Graft System, an advanced solution for Endovascular Aneurysm Repair featuring both suprarenal and infrarenal active fixation. Strategic significance: Expands Terumo&#8217;s EVAR portfolio with a differentiated dual-fixation graft design.<\/p>\n<\/li>\n<li>\n<p>In September 2023, MicroPort&reg; Endovastec&trade; received Thailand FDA approval for three key aortic intervention products, including the Castor&trade; Branched Aortic Stent-Graft and the Minos&trade; Abdominal Aortic Stent-Graft, China&#8217;s first 14F device for infrarenal abdominal aortic aneurysms. Strategic significance: Broadens access to advanced aortic stent-graft technology across Southeast Asia.<\/p>\n<\/li>\n<li>\n<p>North America is expected to account for the highest proportion of the market in 2024.<\/p>\n<\/li>\n<li>\n<p>The principal drivers are the rising burden of cardiovascular diseases; a growing geriatric population; advancements in graft materials and technologies; an increase in minimally invasive and endovascular procedures; and a rising number of dialysis patients requiring vascular access grafts.<\/p>\n<\/li>\n<li>\n<p>The leading Vascular Grafts Companies include BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore &amp; Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, and SCITECH, among others.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><strong>Vascular Grafts Overview<\/strong><\/p>\n<p style=\"text-align: justify\">Vascular grafts, either synthetic or biological, are used to replace, repair, or bypass damaged or blocked blood vessels resulting from cardiovascular disease, restoring proper blood flow. The market spans endovascular grafts, access grafts, peripheral grafts, and other categories, supporting surgical and endovascular interventions for conditions including abdominal aortic aneurysms, peripheral artery disease, and end-stage renal disease requiring hemodialysis access.<\/p>\n<p style=\"text-align: justify\"><strong>Vascular Grafts Market Key Growth Drivers<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>According to the British Heart Foundation (2025), around 640 million people are living with heart and circulatory diseases worldwide, with coronary heart disease alone affecting an estimated 200 million people globally.<\/p>\n<\/li>\n<li>\n<p>The British Heart Foundation (2024) reports that around 56 million women and 45 million men are stroke survivors, and at least 13 million people worldwide live with congenital heart disease, with potentially millions more undiagnosed.<\/p>\n<\/li>\n<li>\n<p>Increasing awareness programs for cardiovascular health, such as World Heart Day led by the World Heart Federation, are playing a vital role in early diagnosis, preventive care, and timely surgical interventions using vascular grafts.<\/p>\n<\/li>\n<li>\n<p>Continuous innovation in biomaterials, including improved synthetic grafts, bioengineered grafts, and tissue-engineered vascular substitutes, is enhancing graft performance, biocompatibility, and long-term patency.<\/p>\n<\/li>\n<li>\n<p>The growing preference for minimally invasive vascular surgeries continues to accelerate adoption of vascular grafts compatible with endovascular techniques, offering reduced hospital stays and faster recovery.<\/p>\n<\/li>\n<li>\n<p>The increasing incidence of chronic kidney disease and end-stage renal disease continues to drive demand for vascular access grafts for hemodialysis, representing a steady, recurring revenue source through 2032.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><em><strong>Get a sneak peek at the Vascular Grafts Market Dynamics @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vascular-grafts-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\">https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Vascular Grafts Market Segment Analysis<\/strong><\/p>\n<p style=\"text-align: justify\">The Vascular Grafts Market by Product Type (EndoVascular Grafts [Abdominal Grafts and Thoracic Grafts], Access Grafts, Peripheral Grafts, and Others), Type (Knitted, Woven, and Others), Material (Synthetic [Polytetrafluoroethylene, Polyester, Polyurethane], Biological, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).<\/p>\n<p style=\"text-align: justify\">By Product Type: Abdominal Grafts are expected to hold a significant share in 2024, driven by the rising prevalence of abdominal aortic aneurysms. According to the Government of the UK (2023), around 314,900 men were offered AAA screening between April 2022 and March 2023, with 1,942 aneurysms detected. Abdominal grafts used in endovascular aneurysm repair offer reduced surgical trauma, shorter hospital stays, and lower postoperative complications, with leading products including Medtronic&#8217;s Endurant&trade; II Stent Graft System and Gore Medical&#8217;s GORE&reg; EXCLUDER&reg; AAA Endoprosthesis.<\/p>\n<p style=\"text-align: justify\">By Geography: North America is expected to account for the highest proportion of the market in 2024, supported by a high prevalence of vascular diseases and well-established healthcare infrastructure. According to the CDC (2024), approximately 4.9% of U.S. adults were diagnosed with coronary heart disease in 2022, and an estimated 12.1 million individuals were projected to have atrial fibrillation by 2023, with over 795,000 people experiencing a stroke each year in the U.S.<\/p>\n<p style=\"text-align: justify\"><em><strong>Which MedTech key players in the Vascular Grafts Market are set to emerge as the trendsetter, explore @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vascular-grafts-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Vascular Grafts Companies<\/strong><\/p>\n<p style=\"text-align: justify\">BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore &amp; Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH, Vascular Graft Solutions, Healionics, and others.<\/p>\n<p style=\"text-align: justify\"><strong>Vascular Grafts Market Restraints<\/strong><\/p>\n<p style=\"text-align: justify\">Despite steady momentum, the Vascular Grafts market faces material constraints. The risk of complications and graft failure due to thrombosis, infection, or poor integration with the patient&#8217;s tissue, along with an increased number of product recalls, may slightly hinder overall market growth during the forecast period.<\/p>\n<p style=\"text-align: justify\"><em><strong>I<\/strong><strong><em>n<\/em>terested in knowing the Vascular Grafts Market by 2032? Click to get a snapshot of the Vascular Grafts Market Trends- <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vascular-grafts-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\">https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Scope of the Vascular Grafts Market Report<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p><strong>Coverage-<\/strong> Global<\/p>\n<\/li>\n<li>\n<p><strong>Study Period-<\/strong> 2022 to 2032<\/p>\n<\/li>\n<li>\n<p><strong>Forecast Period-<\/strong> 2025-2032<\/p>\n<\/li>\n<li>\n<p><strong>Vascular Grafts Companies-<\/strong> BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore &amp; Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH, and others.<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Market Restraints and Regulatory Analysis<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Porter Five Forces Analysis and Market Assessment<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><em><strong>Explore more information of the Vascular Grafts Market Insights @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vascular-grafts-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\">https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Table of Contents<\/strong><\/p>\n<ol style=\"text-align: justify\">\n<li>\n<p>Vascular Grafts Devices Market Report Introduction<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Devices Market Executive Summary<\/p>\n<\/li>\n<li>\n<p>Competitive Landscape<\/p>\n<\/li>\n<li>\n<p>Regulatory Analysis<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Devices Market Key Factors Analysis<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Devices Market Porter&rsquo;s Five Forces Analysis<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Devices Market Assessment<\/p>\n<\/li>\n<li>\n<p>Vascular Grafts Devices Market Company and Product Profiles<\/p>\n<\/li>\n<li>\n<p>KOL Views<\/p>\n<\/li>\n<li>\n<p>Project Approach<\/p>\n<\/li>\n<li>\n<p>About DelveInsight<\/p>\n<\/li>\n<li>\n<p>Disclaimer &amp; Contact Us<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify\"><strong>About Us<\/strong><\/p>\n<p style=\"text-align: justify\">DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.<\/p>\n<p><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kanishk <br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=the-global-vascular-grafts-market-size-is-projected-to-grow-at-a-cagr-of-686-during-the-forecast-period-from-2025-to-2032-delveinsight\">Send Email<\/a><br \/><strong>Phone:<\/strong>  +14699457679<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market\" target=\"_blank\">https:\/\/www.delveinsight.com\/report-store\/vascular-grafts-market<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=the-global-vascular-grafts-market-size-is-projected-to-grow-at-a-cagr-of-686-during-the-forecast-period-from-2025-to-2032-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Vascular Grafts market was valued at USD 1,863.09 million in 2024 and is projected to reach USD 3,153.39 million by 2032, growing at a CAGR of 6.86% during the<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts\/612886"}],"collection":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/comments?post=612886"}],"version-history":[{"count":0,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts\/612886\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/media?parent=612886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/categories?post=612886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/tags?post=612886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}